Followers | 260 |
Posts | 51120 |
Boards Moderated | 18 |
Alias Born | 08/29/2007 |
![](https://investorshub.advfn.com/uicon/108458.png?cb=1482855649)
Friday, July 07, 2023 1:48:58 PM
GoSymbol lookup
Health Care : Biotechnology | Company profile
Azitra Inc is an early-stage clinical biopharmaceutical company. The Company is focused on developing therapies for precision dermatology using engineered proteins and live biotherapeutic products that can be applied topically to treat diseases of the skin. Its platform includes a microbial library comprised of approximately 1,500 bacterial strains that can be screened for therapeutic characteristics. The platform is augmented by artificial intelligence and machine learning technology that analyzes, predicts and helps screen its library of strains for drug-like molecules. Its product ATR-12 is a genetically modified strain of S. epidermidis for treating the orphan disease, Netherton syndrome, a chronic and fatal disease of the skin. Its product ATR-04 is a genetically modified strain of S. epidermidis for treating the papulopustular rash. Its product ATR-01 is a human filaggrin protein for treating ichthyosis vulgaris, a chronic, xerotic (abnormally dry), and scaly skin disease.
I am writing a book, American Cars of 1958. Check often for the latest addition. https://investorshub.advfn.com/American-Cars-of-1958-37252/
Recent AZTR News
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 06/03/2024 08:30:18 PM
- Azitra, Inc. Announces Presentation at the 2024 BIO International Convention • Business Wire • 05/31/2024 12:00:00 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 05/24/2024 08:55:16 PM
- Azitra, Inc. Announces Positive Preclinical Data from ATR-04 Presented at the Society of Investigative Dermatology Annual Meeting • Business Wire • 05/17/2024 12:00:00 PM
- Azitra, Inc. Announces Positive Preclinical Data of ATR-12 and Clinical Design in Netherton Syndrome Presented at the ASGCT Annual Meeting • Business Wire • 05/10/2024 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/09/2024 09:05:14 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/09/2024 09:03:22 PM
- Azitra, Inc. Announces Q1 2024 Financial Results and Provides Business Updates • Business Wire • 05/09/2024 09:00:00 PM
- Azitra, Inc. Announces New Preclinical Data to be Presented at the American Society of Gene and Cell Therapy Meeting • Business Wire • 04/22/2024 08:30:00 PM
- Azitra, Inc. to Present New Data at Three Upcoming Scientific Conferences in May 2024 • Business Wire • 04/18/2024 08:15:00 PM
- Azitra, Inc. Announces Full Year 2023 Financial Results and Provides Business Updates • Business Wire • 03/15/2024 08:15:00 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/26/2024 09:10:47 PM
- Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 02/26/2024 09:05:19 PM
- Azitra, Inc. Announces Closing of Public Offering • Business Wire • 02/16/2024 09:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/16/2024 01:42:23 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/16/2024 01:39:44 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/16/2024 01:38:23 AM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 02/15/2024 09:44:25 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/14/2024 02:15:18 PM
- Azitra, Inc. Announces Pricing of Public Offering • Business Wire • 02/14/2024 03:09:00 AM
- Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses • Edgar (US Regulatory) • 01/19/2024 04:08:45 PM
- Form S-1 - General form for registration of securities under the Securities Act of 1933 • Edgar (US Regulatory) • 01/19/2024 02:19:38 PM
- Azitra, Inc. Strengthens Intellectual Property Portfolio with Newly Granted Patent in the US • Business Wire • 01/16/2024 02:00:00 PM
- Azitra, Inc. to Present at Biotech Showcase 2024 and the Dermatology Summit 2024, Alongside the J.P. Morgan Annual Healthcare Conference • Business Wire • 01/03/2024 02:00:00 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 12/04/2023 09:06:00 PM
FEATURED POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM
Bantec's Howco Short Term Department of Defense Contract Wins Will Exceed $1,100,000 for the current Quarter • BANT • Jun 25, 2024 10:00 AM
ECGI Holdings Targets $9.7 Billion Equestrian Apparel Market with Allon Brand Launch • ECGI • Jun 25, 2024 8:36 AM
Avant Technologies Addresses Progress on AI Supercomputer-Driven Data Centers • AVAI • Jun 25, 2024 8:00 AM
Green Leaf Innovations, Inc. Expands International Presence with New Partnership in Dubai • GRLF • Jun 24, 2024 8:30 AM